Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| erythrocyte | 12 studies | 55% ± 22% | |
| basal cell | 9 studies | 25% ± 10% | |
| ciliated cell | 7 studies | 26% ± 9% | |
| ionocyte | 5 studies | 30% ± 9% | |
| erythroblast | 5 studies | 47% ± 24% | |
| epithelial cell | 5 studies | 36% ± 15% | |
| endothelial cell | 5 studies | 22% ± 6% | |
| abnormal cell | 4 studies | 17% ± 2% | |
| pancreatic A cell | 3 studies | 40% ± 20% | |
| fibroblast | 3 studies | 21% ± 5% | |
| serous secreting cell | 3 studies | 20% ± 3% | |
| enteroendocrine cell | 3 studies | 25% ± 11% | |
| intestinal crypt stem cell | 3 studies | 19% ± 3% | |
| glial cell | 3 studies | 27% ± 14% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 4 studies | 24% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 11990.84 | 258 / 258 | 100% | 135.63 | 230 / 230 |
| esophagus | 100% | 4362.04 | 1445 / 1445 | 100% | 98.71 | 183 / 183 |
| prostate | 100% | 7064.53 | 245 / 245 | 100% | 200.84 | 502 / 502 |
| breast | 100% | 5411.40 | 459 / 459 | 100% | 157.63 | 1116 / 1118 |
| skin | 100% | 5000.19 | 1809 / 1809 | 100% | 261.76 | 471 / 472 |
| ovary | 100% | 10432.04 | 180 / 180 | 100% | 95.53 | 429 / 430 |
| thymus | 100% | 3085.96 | 652 / 653 | 99% | 90.42 | 601 / 605 |
| lung | 100% | 3075.65 | 576 / 578 | 99% | 94.44 | 1149 / 1155 |
| bladder | 100% | 4546.76 | 21 / 21 | 99% | 86.71 | 499 / 504 |
| brain | 100% | 3081.40 | 2633 / 2642 | 99% | 67.47 | 700 / 705 |
| uterus | 100% | 4656.17 | 170 / 170 | 99% | 88.89 | 454 / 459 |
| pancreas | 100% | 2386.72 | 328 / 328 | 99% | 80.66 | 176 / 178 |
| liver | 100% | 3910.90 | 226 / 226 | 99% | 75.04 | 401 / 406 |
| kidney | 100% | 3262.15 | 89 / 89 | 98% | 60.98 | 882 / 901 |
| stomach | 100% | 3755.48 | 359 / 359 | 97% | 93.33 | 278 / 286 |
| intestine | 100% | 4357.06 | 966 / 966 | 96% | 80.12 | 506 / 527 |
| adipose | 100% | 4722.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 483.86 | 80 / 80 |
| muscle | 100% | 5413.14 | 803 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 81.23 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 62.47 | 1 / 1 |
| blood vessel | 100% | 4826.63 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2390.90 | 240 / 241 | 0% | 0 | 0 / 0 |
| heart | 98% | 3259.64 | 842 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 81% | 7752.51 | 755 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 7.98 | 9 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0071392 | Biological process | cellular response to estradiol stimulus |
| GO_0043249 | Biological process | erythrocyte maturation |
| GO_0045648 | Biological process | positive regulation of erythrocyte differentiation |
| GO_0005741 | Cellular component | mitochondrial outer membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FAM210B |
| Protein name | Protein FAM210B, mitochondrial Family with sequence similarity 210 member B |
| Synonyms | C20orf108 PSEC0265 |
| Description | FUNCTION: Plays a role in erythroid differentiation . Involved in cell proliferation and tumor cell growth suppression . Involved in the metabolic reprogramming of cancer cells in a PDK4-dependent manner . . |
| Accessions | H0Y456 ENST00000437418.1 Q96KR6 ENST00000371384.4 |